Literature DB >> 20363753

Activation of glucose-6-phosphate dehydrogenase promotes acute hypoxic pulmonary artery contraction.

Rakhee S Gupte1, Dhawjbahadur K Rawat, Sukrutha Chettimada, Donna L Cioffi, Michael S Wolin, William T Gerthoffer, Ivan F McMurtry, Sachin A Gupte.   

Abstract

Hypoxic pulmonary vasoconstriction (HPV) is a physiological response to a decrease in airway O(2) tension, but the underlying mechanism is incompletely understood. We studied the contribution of glucose-6-phosphate dehydrogenase (Glc-6-PD), an important regulator of NADPH redox and production of reactive oxygen species, to the development of HPV. We found that hypoxia (95% N(2), 5% CO(2)) increased contraction of bovine pulmonary artery (PA) precontracted with KCl or serotonin. Depletion of extracellular glucose reduced NADPH, NADH, and HPV, substantiating the idea that glucose metabolism and Glc-6-PD play roles in the response of PA to hypoxia. Our data also show that inhibition of glycolysis and mitochondrial respiration (indicated by an increase in NAD(+) and decrease in the ATP-to-ADP ratio) by hypoxia, or by inhibitors of pyruvate dehydrogenase or electron transport chain complexes I or III, increased generation of reactive oxygen species, which in turn activated Glc-6-PD. Inhibition of Glc-6-PD decreased Ca(2+) sensitivity to the myofilaments and diminished Ca(2+)-independent and -dependent myosin light chain phosphorylation otherwise increased by hypoxia. Silencing Glc-6-PD expression in PA using a targeted small interfering RNA abolished HPV and decreased extracellular Ca(2+)-dependent PA contraction increased by hypoxia. Similarly, Glc-6-PD expression and activity were significantly reduced in lungs from Glc-6-PD(mut(-/-)) mice, and there was a corresponding reduction in HPV. Finally, regression analysis relating Glc-6-PD activity and the NADPH-to-NADP(+) ratio to the HPV response clearly indicated a positive linear relationship between Glc-6-PD activity and HPV. Based on these findings, we propose that Glc-6-PD and NADPH redox are crucially involved in the mechanism of HPV and, in turn, may play a key role in increasing pulmonary arterial pressure, which is involved in the development of pulmonary hypertension.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20363753      PMCID: PMC2885235          DOI: 10.1074/jbc.M109.092916

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Effects of changes in brain metabolism on levels of pentose phosphate pathway intermediates.

Authors:  F C Kauffman; J G Brown; J V Passonneau; O H Lowry
Journal:  J Biol Chem       Date:  1969-07-10       Impact factor: 5.157

2.  Studies of the mechanism of hypoxic pulmonary vasoconstriction.

Authors:  I F McMurtry; S Rounds; H S Stanbrook
Journal:  Adv Shock Res       Date:  1982

3.  The relative time course of early changes in mitochondrial function and intracellular pH during hypoxia in the isolated toad ventricle strip.

Authors:  J C LaManna; J J Saive; T R Snow
Journal:  Circ Res       Date:  1980-06       Impact factor: 17.367

4.  Vascular smooth muscle: aerobic glycolysis linked to sodium and potassium transport processes.

Authors:  R J Paul; M Bauer; W Pease
Journal:  Science       Date:  1979-12-21       Impact factor: 47.728

5.  Catalytic mechanism and substrate specificity of the beta-subunit of the voltage-gated potassium channel.

Authors:  Srinivas M Tipparaju; Oleg A Barski; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Biochemistry       Date:  2008-08-02       Impact factor: 3.162

6.  Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase.

Authors:  Karen A Fagan; Masahiko Oka; Natalie R Bauer; Sarah A Gebb; D Dunbar Ivy; Kenneth G Morris; Ivan F McMurtry
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-02-20       Impact factor: 5.464

7.  Pentose phosphate pathway coordinates multiple redox-controlled relaxing mechanisms in bovine coronary arteries.

Authors:  Sachin A Gupte; Muhammad Arshad; Steven Viola; Pawel M Kaminski; Zoltan Ungvari; Golam Rabbani; Akos Koller; Michael S Wolin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-08-21       Impact factor: 4.733

Review 8.  Calcium, mitochondria and oxygen sensing in the pulmonary circulation.

Authors:  Jeremy P T Ward; Vladimir A Snetkov; Philip I Aaronson
Journal:  Cell Calcium       Date:  2004 Sep-Oct       Impact factor: 6.817

9.  Dehydroepiandrosterone (DHEA) prevents and reverses chronic hypoxic pulmonary hypertension.

Authors:  Sébastien Bonnet; Eric Dumas-de-La-Roque; Hugues Bégueret; Roger Marthan; Michael Fayon; Pierre Dos Santos; Jean-Pierre Savineau; Etienne-Emile Baulieu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-23       Impact factor: 11.205

10.  Regulation of the pentose phosphate cycle.

Authors:  L V Eggleston; H A Krebs
Journal:  Biochem J       Date:  1974-03       Impact factor: 3.857

View more
  29 in total

1.  Glucose-6-phosphate dehydrogenase is a regulator of vascular smooth muscle contraction.

Authors:  Rakhee S Gupte; Hirotaka Ata; Dhawjbahadur Rawat; Madoka Abe; Mark S Taylor; Rikuo Ochi; Sachin A Gupte
Journal:  Antioxid Redox Signal       Date:  2010-10-25       Impact factor: 8.401

2.  Metabolism and Redox in Pulmonary Vascular Physiology and Pathophysiology.

Authors:  Norah Alruwaili; Sharath Kandhi; Dong Sun; Michael S Wolin
Journal:  Antioxid Redox Signal       Date:  2018-12-21       Impact factor: 8.401

Review 3.  NADPH oxidase-derived ROS and the regulation of pulmonary vessel tone.

Authors:  G Frazziano; H C Champion; P J Pagano
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

4.  20-HETE-induced mitochondrial superoxide production and inflammatory phenotype in vascular smooth muscle is prevented by glucose-6-phosphate dehydrogenase inhibition.

Authors:  Anand Lakhkar; Vidhi Dhagia; Sachindra Raj Joshi; Katherine Gotlinger; Dhara Patel; Dong Sun; Michael S Wolin; Michal L Schwartzman; Sachin A Gupte
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-02-26       Impact factor: 4.733

5.  Glucose-6-phosphate dehydrogenase increases Ca2+ currents by interacting with Cav1.2 and reducing intrinsic inactivation of the L-type calcium channel.

Authors:  Rakhee Gupte; Vidhi Dhagia; Petra Rocic; Rikuo Ochi; Sachin A Gupte
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-05-22       Impact factor: 4.733

6.  Roles for redox mechanisms controlling protein kinase G in pulmonary and coronary artery responses to hypoxia.

Authors:  Boon Hwa Neo; Sharath Kandhi; Michael S Wolin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-16       Impact factor: 4.733

7.  Hypoxia-induced glucose-6-phosphate dehydrogenase overexpression and -activation in pulmonary artery smooth muscle cells: implication in pulmonary hypertension.

Authors:  Sukrutha Chettimada; Rakhee Gupte; Dhwajbahadur Rawat; Sarah A Gebb; Ivan F McMurtry; Sachin A Gupte
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-12-05       Impact factor: 5.464

8.  Vascular smooth muscle cell contractile protein expression is increased through protein kinase G-dependent and -independent pathways by glucose-6-phosphate dehydrogenase inhibition and deficiency.

Authors:  Sukrutha Chettimada; Sachindra Raj Joshi; Vidhi Dhagia; Alessandro Aiezza; Thomas M Lincoln; Rakhee Gupte; Joseph M Miano; Sachin A Gupte
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-08-12       Impact factor: 4.733

9.  Contractile protein expression is upregulated by reactive oxygen species in aorta of Goto-Kakizaki rat.

Authors:  Sukrutha Chettimada; Hirotaka Ata; Dhwajbahadur K Rawat; Salil Gulati; Andrea G Kahn; John G Edwards; Sachin A Gupte
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-08       Impact factor: 4.733

10.  Roles for cytosolic NADPH redox in regulating pulmonary artery relaxation by thiol oxidation-elicited subunit dimerization of protein kinase G1α.

Authors:  Boon Hwa Neo; Dhara Patel; Sharath Kandhi; Michael S Wolin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-05-24       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.